Chlamydia Testing: What to Expect and Why It Matters

Key takeaways

• Chlamydia is a bacterial STI that frequently produces no symptoms, so testing rather than symptoms is the only way to confirm infection.
• Nucleic acid amplification tests (NAATs) are the recommended method for detecting chlamydia and can be performed on urine or swab samples.
• Routine annual screening is recommended for sexually active women under 25, men who have sex with men, and others at increased risk.
• Chlamydia is curable with antibiotics, and partners should be treated to prevent reinfection.
• Rectal and pharyngeal testing may be recommended for people with relevant exposure, since standard urine tests do not detect infections at those sites.

What Chlamydia Testing Detects

Chlamydia testing looks for evidence of Chlamydia trachomatis, the bacterium that causes the infection. Modern testing almost always uses nucleic acid amplification tests, or NAATs, which detect the organism's genetic material. NAATs are highly sensitive and specific, meaning they are good at finding true infections and unlikely to produce false positives.

Testing is not the same as diagnosis by symptoms. Many people with chlamydia have no signs of infection, and when symptoms do occur they can overlap with other conditions. A laboratory test is what distinguishes chlamydia from other infections and guides correct treatment.

Who Should Be Screened and How Often

Public health guidelines recommend routine chlamydia screening for sexually active women age 25 and younger, and for older women with risk factors such as a new partner or multiple partners. Annual screening is typical. Men who have sex with men are also advised to be screened at sites of exposure, including urine, rectum, and throat.

Pregnant women are often screened because chlamydia can affect pregnancy outcomes and can be passed to a newborn during delivery. Anyone with a new sexual partner, a partner diagnosed with an STI, or symptoms suggesting infection should consider testing regardless of age or routine schedule.

How Samples Are Collected

The most common sample for chlamydia testing is a first-catch urine specimen, which is easy to collect and non-invasive. For women, a vaginal swab may be self-collected in a clinic or at home, and it performs similarly to a clinician-collected swab. For people with rectal or throat exposure, swabs from those sites may be recommended.

Sample collection instructions matter. A first-catch urine sample should be collected before urinating for at least one to two hours, depending on the instructions provided, because a diluted sample can reduce test accuracy. Swabs should be used as directed, and samples should reach the laboratory promptly.

Understanding Results and Treatment

A positive chlamydia test means the bacterium was detected and treatment is needed. Chlamydia is curable with antibiotics prescribed by a healthcare provider. It is important to take the medication exactly as directed and to avoid sexual activity until treatment is completed and any follow-up guidance is met.

A negative test generally means no infection was detected, but timing matters. Testing too soon after exposure can miss an infection because it takes time for the bacterium to reach detectable levels. If exposure occurred recently, a provider may recommend repeat testing after an appropriate window. Partners of someone with a positive result should also be evaluated and treated to prevent reinfection.

Frequently Asked Questions

Sources

• CDC: Chlamydia - CDC Detailed Fact Sheet
• CDC: Chlamydia Screening Recommendations
• MedlinePlus: Chlamydia Infections
• Mayo Clinic: Chlamydia
• NIH: Chlamydia